scholarly article | Q13442814 |
P2093 | author name string | Timothy M Hall | |
Kathryn E Hamilton | |||
Marie-Pier Tétreault | |||
Kelly A Whelan | |||
P2860 | cites work | Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice | Q24303752 |
Self-consumption: the interplay of autophagy and apoptosis | Q26828473 | ||
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo | Q27644291 | ||
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy | Q27695718 | ||
Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase | Q30427499 | ||
Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy | Q30646716 | ||
Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo | Q33693093 | ||
Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma | Q33746474 | ||
Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature | Q33778324 | ||
Association of the expression of unc-51-Like kinase 1 with lymph node metastasis and survival in patients with esophageal squamous cell carcinoma | Q33815958 | ||
Frequent mutation of the p53 gene in human esophageal cancer | Q33927516 | ||
Autophagy is required for glucose homeostasis and lung tumor maintenance | Q34017543 | ||
Autophagy-related proteins LC3 and Beclin-1 impact the efficacy of chemoradiation on esophageal squamous cell carcinoma | Q47950975 | ||
High p53 and MAP1 light chain 3A co-expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. | Q51028534 | ||
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus | Q81211241 | ||
LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers | Q81770939 | ||
Clinical observation and therapeutic evaluation of Rh-endostatin combined with DP regimen in treating patients with advanced esophageal cancer | Q85210401 | ||
Esophageal carcinoma | Q86401144 | ||
Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell Carcinoma | Q87466895 | ||
MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma | Q88727107 | ||
High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma | Q34029203 | ||
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma | Q34372972 | ||
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma | Q34372977 | ||
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors | Q34372994 | ||
Identification of genomic alterations in oesophageal squamous cell cancer | Q34412178 | ||
The role for autophagy in cancer | Q35242506 | ||
Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. | Q35676481 | ||
Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer | Q35728238 | ||
A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors | Q35852826 | ||
Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency | Q35991524 | ||
Keap1 degradation by autophagy for the maintenance of redox homeostasis | Q36187388 | ||
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma | Q36322862 | ||
Recombinant human endostatin combined with definitive chemoradiotherapy as primary treatment for patients with unresectable but without systemic metastatic squamous cell carcinoma of the oesophagus | Q36407099 | ||
The expression of LC-3 is related to tumor suppression through angiogenesis in esophageal cancer | Q37342242 | ||
Recent insights into the function of autophagy in cancer | Q37343004 | ||
Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression | Q37469223 | ||
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling | Q37620713 | ||
Oncogenic functions of the transcription factor Nrf2. | Q38118827 | ||
Radiation-induced autophagy promotes esophageal squamous cell carcinoma cell survival via the LKB1 pathway | Q38775695 | ||
Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance. | Q38834623 | ||
Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance | Q38955141 | ||
OV6+ cancer stem cells drive esophageal squamous cell carcinoma progression through ATG7-dependent β-catenin stabilization | Q38993592 | ||
Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma | Q39015925 | ||
Insulin enhances apoptosis induced by cisplatin in human esophageal squamous cell carcinoma EC9706 cells related to inhibition of autophagy | Q39033364 | ||
Integrated genomic characterization of oesophageal carcinoma | Q39041152 | ||
Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma | Q39173601 | ||
A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers | Q39411472 | ||
Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma | Q39553486 | ||
The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells | Q39739756 | ||
Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells | Q39757793 | ||
High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma | Q41911745 | ||
Targeting autophagy in cancer | Q41912265 | ||
Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis | Q41915730 | ||
Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics | Q41933492 | ||
Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells | Q41982178 | ||
Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma. | Q47136345 | ||
Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma | Q47137655 | ||
Beclin 1 expression is associated with the occurrence and development of esophageal squamous cell carcinoma | Q47375813 | ||
P921 | main subject | autophagy | Q288322 |
esophageal squamous cell carcinoma | Q108442577 | ||
P304 | page(s) | 12-19 | |
P577 | publication date | 2018-04-17 | |
P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
P1476 | title | Autophagy as a cytoprotective mechanism in esophageal squamous cell carcinoma. | |
P478 | volume | 41 |
Search more.